Helicobacter Pylori Infection in Migraine Patients: A Case Control Study
Abstract
Background: Worldwide about 12-15% of population complains of migraine at some point of their lives. Gastrointestinal disorders and infections including Helicobacter pylori (H. Pylori) have been the focus of many researches to delineate their relationship with migraine headache Objectives: To assess the coexistence of H. pylori and migraine headache and to assess the effect of H. pylori eradication on migraine impact among Egyptian patients. Methodology: In this case control study, eighty migraine patients and eighty age and sex matched healthy controls were enrolled. Migraine impact on patient’s life was assessed on initial case evaluation by Migraine Disability Assessment Test (MIDAS1). H. pylori stool antigen test was done for all participants. H. pylori infected cases received levofloxacin based triple therapy and symptomatic control group received first line clarithromycin based therapy for 2 weeks. H. pylori stool antigen test was repeated 4 weeks after treatment regimen was completed. Reassessment of all cases by MIDAS2 was also done after 3 months of completing therapy. Results: The predominance of female gender was reported in migraine patients. Case group had statistically significant more GIT manifestations as heart burn, epigastric pain and GIT bleeding compared with control volunteers. There was significantly higher prevalence of H. pylori infection in patient group than controls (P <0.05). H. pylori eradication rate was significantly higher in levofloxacin…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.